BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 19092266)

  • 1. Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy.
    Kudo M
    Oncology; 2008; 75 Suppl 1():1-12. PubMed ID: 19092266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2008 Okuda lecture: Management of hepatocellular carcinoma: from surveillance to molecular targeted therapy.
    Kudo M
    J Gastroenterol Hepatol; 2010 Mar; 25(3):439-52. PubMed ID: 20370723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positioning of a molecular-targeted agent, sorafenib, in the treatment algorithm for hepatocellular carcinoma and implication of many complete remission cases in Japan.
    Kudo M; Ueshima K
    Oncology; 2010 Jul; 78 Suppl 1():154-66. PubMed ID: 20616599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The diagnostic approach to hepatocellular carcinoma].
    Schacherer D; Schoelmerich J; Zuber-Jerger I
    Z Gastroenterol; 2007 Oct; 45(10):1067-74. PubMed ID: 17924305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia.
    Han KH; Kudo M; Ye SL; Choi JY; Poon RT; Seong J; Park JW; Ichida T; Chung JW; Chow P; Cheng AL
    Oncology; 2011; 81 Suppl 1():158-64. PubMed ID: 22212951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markers for hepatocellular carcinoma.
    Wu AH; Sell S
    Immunol Ser; 1990; 53():403-22. PubMed ID: 1713067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Will Gd-EOB-MRI change the diagnostic algorithm in hepatocellular carcinoma?
    Kudo M
    Oncology; 2010 Jul; 78 Suppl 1():87-93. PubMed ID: 20616589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma.
    Marrero JA
    Curr Opin Gastroenterol; 2006 May; 22(3):248-53. PubMed ID: 16550039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.
    Choi JY
    Oncology; 2011; 81 Suppl 1():141-7. PubMed ID: 22212948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early hepatocellular carcinoma: pathology, imaging, and therapy.
    Takayama T; Makuuchi M; Kojiro M; Lauwers GY; Adams RB; Wilson SR; Jang HJ; Charnsangavej C; Taouli B
    Ann Surg Oncol; 2008 Apr; 15(4):972-8. PubMed ID: 18236118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment options for hepatocellular carcinoma.
    Sandhu DS; Tharayil VS; Lai JP; Roberts LR
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):81-92. PubMed ID: 19072372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and multimodal therapy for hepatocellular carcinoma].
    Kolligs FT; Hoffmann RT; op den Winkel M; Bruns CJ; Herrmann K; Jakobs TF; Lamerz R; Trumm C; Zech CJ; Wilkowski R; Graeb C
    Z Gastroenterol; 2010 Feb; 48(2):274-88. PubMed ID: 20119895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?
    Lencioni R; Chen XP; Dagher L; Venook AP
    Oncologist; 2010; 15 Suppl 4():42-52. PubMed ID: 21115580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma.
    Llovet JM; Fuster J; Bruix J;
    Liver Transpl; 2004 Feb; 10(2 Suppl 1):S115-20. PubMed ID: 14762851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of hepatocellular carcinoma.
    El-Serag HB; Marrero JA; Rudolph L; Reddy KR
    Gastroenterology; 2008 May; 134(6):1752-63. PubMed ID: 18471552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future treatment option for hepatocellular carcinoma: a focus on brivanib.
    Kudo M
    Dig Dis; 2011; 29(3):316-20. PubMed ID: 21829023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real practice of hepatocellular carcinoma in Japan: conclusions of the Japan Society of Hepatology 2009 Kobe Congress.
    Kudo M
    Oncology; 2010 Jul; 78 Suppl 1():180-8. PubMed ID: 20616602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBV-related HCC, clinical issues and therapy.
    Iavarone M; Colombo M
    Dig Liver Dis; 2011 Jan; 43 Suppl 1():S32-9. PubMed ID: 21195370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modern diagnosis and management of hepatocellular carcinoma.
    Marrero JA; Welling T
    Clin Liver Dis; 2009 May; 13(2):233-47. PubMed ID: 19442916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the treatment of hepatocellular carcinoma.
    Singal AG; Marrero JA
    Curr Opin Gastroenterol; 2010 May; 26(3):189-95. PubMed ID: 20224395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.